# Trifarma S.p.A. – FDA Inspection, Jan 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/trifarma-spa/cbf49105-8cf3-4df8-ada8-c24df5a1b33f
Source feed: FDA_Inspections

> FDA inspection 1013013 of Trifarma S.p.A., January 27, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1013013
- Company Name: Trifarma S.p.A.
- Inspection Date: 2017-01-27
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1289850 - 2024-09-27
- FDA Inspection 1100281 - 2019-02-28
- [FDA Inspection 924404 - 2015-02-27](https://www.keypedia.com/records/fda_inspections/trifarma-spa/56efdb65-40e4-4636-a348-8876f8de863e)
- [FDA Inspection 866279 - 2014-01-29](https://www.keypedia.com/records/fda_inspections/trifarma-spa/d1e418f1-8571-40dc-b208-5fcce0d7e9c3)
- FDA Inspection 650163 - 2010-01-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/zachary-l-stamm/b729fab9-4d31-4c70-b5b3-e8b6207769c6)

Company: https://www.keypedia.com/companies/trifarma-spa/254420da-cc29-4c52-9e1a-e75bcba38a17

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c